BGSRX | FSPTX | BGSRX / FSPTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 44 years | - |
Gain YTD | 2.146 | 0.027 | 7,917% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.18B | 16.7B | 37% |
Annual Yield % from dividends | 0.00 | 0.01 | - |
Returns for 1 year | 16.88 | 17.97 | 94% |
Returns for 3 years | 40.29 | 52.14 | 77% |
Returns for 5 years | 77.47 | 69.63 | 111% |
Returns for 10 years | 330.96 | 206.56 | 160% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETHSX | 13.78 | -0.03 | -0.22% |
Eaton Vance Worldwide Health Sci A | |||
FFEFX | 14.79 | -0.19 | -1.27% |
Nuveen Dividend Value R6 | |||
PEQLX | 35.86 | -0.58 | -1.59% |
Putnam Large Cap Value R5 | |||
BRSSX | 14.32 | -0.35 | -2.39% |
MFS Blended Research Small Cap Eq R2 | |||
AGCWX | 17.70 | -0.50 | -2.75% |
American Century Global Small Cap R |